Eva F. Zwertbroek

Eva F. Zwertbroek

Auto-generated profile, based on publicly available information

Eva F. Zwertbroek

Departments of Obstetrics and Gynaecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2019 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
TBT. P. Bernardes
T. P. Bernardes
EZE. F. Zwertbroek
E. F. Zwertbroek
KBK. Broekhuijsen
K. Broekhuijsen
CKC. Koopmans
C. Koopmans
KBK. Boers
K. Boers
HGH. Groen
H. Groen
Objective: Hypertensive disorders affect 3–10% of pregnancies. Delayed delivery carries maternal risks, while early delivery increases fetal risk, so appropriate timing is important. The aim of this study was to compare immediate delivery with expectant management for prevention of adverse maternal and neonatal outcomes in women with hypertensive disease in pregnancy.Methods: CENTRAL, PubMed, MEDLINE and ClinicalTrials.gov were searched for randomized controlled trials comparing immediate delivery to expectant management in women presenting with gestational hypertension or pre‐eclampsia without severe features from 34 weeks of gestation. The primary neonatal outcome was respiratory distress syndrome (RDS) and the primary maternal outcome was a composite of HELLP syndrome and eclampsia. The PRISMA‐IPD guideline was followed and a two‐stage meta‐analysis approach was used. Relative risks (RR) and numbers needed to treat or harm (NNT/NNH) with 95% CI were calculated to evaluate the effect of the intervention.Results: Main outcomes were available for 1724 eligible women. Compared with expectant management, immediate delivery reduced the composite risk of HELLP syndrome and eclampsia in all women (0.8% vs 2.8%; RR, 0.33 (95% CI, 0.15–0.73); I2 = 0%; NNT, 51 (95% CI, 31.1–139.3)) as well as in the pre‐eclampsia subgroup (1.1% vs 3.5%; RR, 0.39 (95% CI, 0.15–0.98); I2 = 0%). Immediate delivery increased RDS risk (3.4% vs 1.6%; RR, 1.94 (95% CI 1.05–3.6); I2 = 24%; NNH, 58 (95% CI, 31.1–363.1)), but depended upon gestational age. Immediate delivery in the 35th week of gestation increased RDS risk (5.1% vs 0.6%; RR, 5.5 (95% CI, 1.0–29.6); I2 = 0%), but immediate delivery in the 36th week did not (1.5% vs 0.4%; RR, 3.4 (95% CI, 0.4–30.3); I2 not applicable).Conclusion: In women with hypertension in pregnancy, immediate delivery reduces the risk of maternal complications, whilst the effect on the neonate depends on gestational age. Specifically, women with a‐priori higher risk of progression to HELLP, such as those already presenting with pre‐eclampsia instead of gestational hypertension, were shown to benefit from earlier delivery. © 2019 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.

26 April 2022 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
ABAlice Beardmore-Gray
Alice Beardmore-Gray
PSPaul Seed
Paul Seed
JFJessica Fleminger
Jessica Fleminger
EZEva Zwertbroek
Eva Zwertbroek
TBThomas Bernardes
Thomas Bernardes
LCLucy C. Chappell
Lucy C. Chappell
Pregnancy hypertension is a leading cause of maternal and perinatal mortality and morbidity. Between 34+0 and 36+6 weeks gestation, it is uncertain whether planned delivery could reduce maternal complications without serious neonatal consequences. In this individual participant data meta-analysis, we aimed to compare planned delivery to expectant management, focusing specifically on women with preeclampsia. We performed an electronic database search using a prespecified search strategy, including trials published between January 1, 2000 and December 18, 2021. We sought individual participant-level data from all eligible trials. We included women with singleton or multifetal pregnancies with preeclampsia from 34 weeks gestation onward. The primary maternal outcome was a composite of maternal mortality or morbidity. The primary perinatal outcome was a composite of perinatal mortality or morbidity. We analyzed all the available data for each prespecified outcome on an intention-to-treat basis. For primary individual patient data analyses, we used a 1-stage fixed effects model. We included 1790 participants from 6 trials in our analysis. Planned delivery from 34 weeks gestation onward significantly reduced the risk of maternal morbidity (2.6% vs 4.4%; adjusted risk ratio, 0.59; 95% confidence interval, 0.36-0.98) compared with expectant management. The primary composite perinatal outcome was increased by planned delivery (20.9% vs 17.1%; adjusted risk ratio, 1.22; 95% confidence interval, 1.01-1.47), driven by short-term neonatal respiratory morbidity. However, infants in the expectant management group were more likely to be born small for gestational age (7.8% vs 10.6%; risk ratio, 0.74; 95% confidence interval, 0.55-0.99). Planned early delivery in women with late preterm preeclampsia provides clear maternal benefits and may reduce the risk of the infant being born small for gestational age, with a possible increase in short-term neonatal respiratory morbidity. The potential benefits and risks of prolonging a pregnancy complicated by preeclampsia should be discussed with women as part of a shared decision-making process.

5 January 2021 in Fetal Diagnosis and Therapy
Verified
Journal Article
Open access
PDF file
EZEva F. Zwertbroek
Eva F. Zwertbroek
HGHenk Groen
Henk Groen
FFFederica Fontanella
Federica Fontanella
LMLuana Maggio
Luana Maggio
LMLaura Marchi
Laura Marchi
CBCaterina M. Bilardo
Caterina M. Bilardo
Objective: The aim of the study was to evaluate the performance of the first-trimester Fetal Medicine Foundation (FMF) screening algorithm, including maternal characteristics and medical history, blood pressure, pregnancy-associated plasma protein A and placenta growth factor, crown rump length, and uterine artery pulsatility index, for the prediction of preeclampsia in a high-risk population in the Netherlands. Methods: This is a prospective cohort including nulliparous women and women with preeclampsia or intrauterine growth restriction in previous pregnancy. We screened patients at 11–14 weeks of gestation to calculate the risk for preeclampsia. The primary outcome was preeclampsia and gestational age at delivery. Performance of the model was evaluated by area under the receiver operating characteristic (ROC) curves (AUCs) and calibration graphs; based on the ROC curves, optimal predicted risk cutoff values for our study population were defined. Results: We analyzed 362 women, of whom 22 (6%) developed preeclampsia. The algorithm showed fair discriminative performance for preeclampsia <34 weeks (AUC 0.81; 95% CI 0.65–0.96) and moderate discriminative performance for both preeclampsia <37 weeks (AUC 0.71; 95% CI 0.51–0.90) and <42 weeks (AUC 0.71; 95% CI 0.61–0.81). Optimal cutoffs based on our study population for preeclampsia <34, <37, and <42 weeks were 1:250, 1:64, and 1:22, respectively. Calibration was poor. Conclusions: Performance of the FMF preeclampsia algorithm was satisfactory to predict early and preterm preeclampsia and less satisfactory for term preeclampsia in a high-risk population. However, by addressing some of the limitations of the present study, the performance can potentially improve. This is essential before implementation is considered.

1 August 2019 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
EZEva F. Zwertbroek
Eva F. Zwertbroek
MFMaureen T.M. Franssen
Maureen T.M. Franssen
KBKim Broekhuijsen
Kim Broekhuijsen
JLJosje Langenveld
Josje Langenveld
HBHenk Bremer
Henk Bremer
HGHenk Groen
Henk Groen

1 January 2020 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
EZEva F. Zwertbroek
Eva F. Zwertbroek
JZJulia Zwertbroek
Julia Zwertbroek
KBKim Broekhuijsen
Kim Broekhuijsen
MFMaureen T.M. Franssen
Maureen T.M. Franssen
WGWessel Ganzevoort
Wessel Ganzevoort
HGHenk Groen
Henk Groen

29 December 2016 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Closed access
PDF file
EZEva F. Zwertbroek
Eva F. Zwertbroek
KBKim Broekhuijsen
Kim Broekhuijsen
JLJosje Langenveld
Josje Langenveld
GBGert‐Jan van Baaren
Gert‐Jan van Baaren
PBPaul P. van Den Berg
Paul P. van Den Berg
TGthe HYPITAT‐II Study Group
the HYPITAT‐II Study Group